Beyond Numbers: How Dr Pyarilal Tripathy is transforming the dreams of Parenthood through IVF.

India, July 8 -- Bargarh, Odisha | July 2025 - In a country where Infertility is misunderstood and criticised and is emotionally draining, one man and his team have silently been changing lives, turning sadness into happiness.Dr Pyarilal Tripathy founder and Chief Fertility Specialist at Kishori IVF is not only delivering results, but also hope and dreams.Over the past 13 years, from 2012 to 2025, over 2100 families have found happiness and a new beginning at Kishori IVF. But this milestone not ...


Clinical Trial: Functionality verification test by continuous intake of test food: a randomized, double blind, placebo-controlled study (Japan)

Tokyo, July 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058384) titled 'Functionality verification test by continuous intake of test food' on July 8. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - Japan Clinical Trial Association Condition: Condition - Healthy adult Classification by malignancy - Oth...


Clinical Trial: Use-result survey to evaluate the safety and outcome of QUVIVIQ use in patients with insomnia (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058402) titled 'Use-result survey to evaluate the safety and outcome of QUVIVIQ use in patients with insomnia' on July 8. Study Type: Observational Primary Sponsor: Institute - Nxera Pharma Japan Co.,Ltd Condition: Condition - insomnia Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - To evaluate the safety and efficacy of QUVIVIQ Tablet...


Clinical Trial: Evaluation of short-term changes in glycemic management indicators before and after initiating once-weekly basal insulin icodec: A multicenter, exploratory, prospective, single-arm observational study (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058398) titled 'Evaluation of short-term changes in glycemic management indicators before and after initiating once-weekly basal insulin' on July 8. Study Type: Observational Primary Sponsor: Institute - Asahikawa Medical University Condition: Condition - Type 2 diabetes Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - To evaluate the s...


Clinical Trial: The effect of press needles on myofascial pain syndrome in patients with advanced cancer (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058406) titled 'The effect of press needles on myofascial pain syndrome in patients with advanced cancer' on July 8. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control Primary Sponsor: Institute - NHO Hokkaido Cancer Center Condition: Condition - myofascial pain syndrome Classifica...


Clinical Trial: Evaluation of the Behavioral Change Effects of an Integrated Program on Oral Health and Food Education for Elementary School Children (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058399) titled 'Evaluation of the Behavioral Change Effects of an Integrated Program on Oral Health and Food Education for Elementary School Children' on July 8. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled Primary Sponsor: Institute - Institute of Science Tokyo Condition: Co...


Clinical Trial: Utility of EUS shear wave elastography for diagnosis in pancreatic fibrosis using surgical specimens (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058397) titled 'Utility of EUS shear wave elastography for diagnosis in pancreatic fibrosis using surgical specimens' on July 8. Study Type: Observational Primary Sponsor: Institute - Wakayama Medical University Condition: Condition - chronic pancreatitis Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - The aim of this study is to demon...


Clinical Trial: Japan Antiretroviral Decision and CAB+RPV Implementation Study (Japan)

Tokyo, July 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058396) titled 'Study on Decision-Making and Long-Acting Agents in HIV Treatment' on July 8. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled Primary Sponsor: Institute - International University of Health and Welfare Condition: Condition - HIV infection Classification by maligna...


JAPAN-UK-ITALY TRILATERAL DEFENSE MINISTERIAL MEETING

TOKYO, July 7 -- Japan Air Self-Defense Force (JASDF) issued the following news release: On July 7, 2025, commencing at 17:00 for approximately 2 hours, Defense Minister Nakatani virtually attended the Trilateral Defense Ministerial Meeting via teleconference, with the Rt Hon John Healey MP, Secretary of State for Defence of the United Kingdom of Great Britain and Northern Ireland, and H.E. Mr. Guido Crosetto, Minister of Defense of the Italian Republic. At this meeting, the three Ministers dis...


JAPAN-NAURU BILATERAL EXERCISE

TOKYO, July 7 -- JMSDF issued the following news: The Indo-Pacific Deployment 2025 (IPD25) unit conducted a bilateral exercise with the Nauru Police Force Maritime Unit as described below in order to strengthen cooperation to realize a "Free and Open Indo-Pacific". 1. Objectives (1) To improve the JMSDF's tactical capabilities (2) To strengthen cooperation with the Nauru Police Force Maritime Unit 2. Period June 30 - July 4 3. Exercise Area Yaren and in the vicinity of Yaren 4. Participating...